Down-regulation of argininosuccinate synthetase is associated with cisplatin resistance in hepatocellular carcinoma cell lines: implications for PEGylated arginine deiminase combination therapy

Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

El‐Serag, H. B., & Rudolph, K. L. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.061 · Cited by 5,401 · see citing works

Tumour heterogeneity in the clinic

Bedard, P. L., Hansen, A. R., Ratain, M. J., & Siu, L. L. (2013) · Nature · doi:10.1038/nature12627 · Cited by 1,205 · see citing works

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Behrens, B. C., Hamilton, T. C., Masuda, H., Grotzinger, K. R., Whang‐Peng, J., Louie, K. G., Knutsen, T., McKoy, W. M., Young, R. C., & Ozols, R. F. (1987) · PubMed · Cited by 498 · see citing works

Hepatocellular carcinoma

Schafer, D. F., & Sorrell, M. F. (1999) · The Lancet · doi:10.1016/s0140-6736(98)09148-x · Cited by 454 · see citing works

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer

Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441 · see citing works

Argininosuccinate synthetase from the urea cycle to the citrulline–NO cycle

Husson, A., Brasse‐Lagnel, C., Fairand, A., Renouf, S., & Lavoinne, A. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03559.x · Cited by 329 · see citing works

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers

Dillon, B. J., Prieto, V. G., Curley, S. A., Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2004) · Cancer · doi:10.1002/cncr.20057 · Cited by 317 · see citing works

Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis

Kim, R. H., Coates, J. M., Bowles, T. L., McNerney, G. P., Sutcliffe-Goulden, J., Jung, J. U., Gandour‐Edwards, R. F., Chuang, F. Y. S., Bold, R. J., & Kung, H.-J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3157 · Cited by 316 · see citing works

Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo.

Ensor, M., Holtsberg, F. W., Bomalaski, J. S., & Clark, M. A. (2002) · PubMed · Cited by 315 · see citing works

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies

Izzo, F., Marra, P., Beneduce, G., Castello, G., Vallone, P., De Rosa, V., Cremona, F., Ensor, C. M., Holtsberg, F. W., Bomalaski, J. S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.11.120 · Cited by 250 · see citing works

Pegylated arginine deiminase treatment of patients with metastatic melanoma: results from phase I and II studies

Ascierto, P. A., Scala, S., Castello, G., Daponte, A., Simeone, E., Ottaiano, A., Beneduce, G., De Rosa, V., Izzo, F., Melucci, M. T., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.0933 · Cited by 238 · see citing works

Epigenetics as a mechanism driving polygenic clinical drug resistance

Glasspool, R. M., Teodoridis, J. M., & Brown, R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603024 · Cited by 236 · see citing works

Arginine Deprivation as a Targeted Therapy for Cancer

Feun, L. G., You, M., Wu, C., Kuo, M. T., Wangpaichitr, M., Spector, S. A., & Savaraj, N. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784246199 · Cited by 235 · see citing works

Targeting arginine-dependent cancers with arginine-degrading enzymes: opportunities and challenges

Phillips, M. M., Sheaff, M. T., & Szlosarek, P. W. (2013) · Cancer Research and Treatment · doi:10.4143/crt.2013.45.4.251 · Cited by 229 · see citing works

Arginine Starvation Impairs Mitochondrial Respiratory Function in ASS1-Deficient Breast Cancer Cells

Qiu, F., Chen, Y.-R., Liu, X., Chu, C.-Y., Shen, L., Xu, J., Gaur, S., Forman, H. J., Zhang, H., Zheng, S. S., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004761 · Cited by 218 · see citing works

Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers

Wei, S. H., Chen, C., Strathdee, G. R., Harnsomburana, J., Shyu, C., Rahmatpanah, F. B., Shi, H., Ng, S. W., Yan, P. S., Nephew, K. P., et al. (2011) · PubMed · doi:10.25405/ncl.34289580 · Cited by 198 · see citing works

Phase II Study of Pegylated Arginine Deiminase for Nonresectable and Metastatic Hepatocellular Carcinoma

Glazer, E. S., Piccirillo, M., Albino, V., Giacomo, R. D., Palaia, R., Mastro, A. A., Beneduce, G., Castello, G., Rosa, V. D., Petrillo, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.7765 · Cited by 187 · see citing works

In vivo Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Szlosarek, P. W., Klampatsa, A., Pallaska, A., Sheaff, M. T., Smith, P., Crook, T., Grimshaw, M. J., Steele, J. P. C., Rudd, R., Balkwill, F. R., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1101 · Cited by 181 · see citing works

Argininosuccinate synthase: at the center of arginine metabolism.

(2011) · Europe PMC (PubMed Central) · Cited by 176 · see citing works

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma

Syed, N., Langer, J., Janczar, K., Singh, P., Nigro, C. L., Lattanzio, L., Coley, H. M., Hatzimichael, E. C., Bomalaski, J. S., Szlosarek, P. W., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2012.197 · Cited by 167 · see citing works

Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation<i>via</i>arginine deiminase

Yoon, C., Shim, Y., Kim, E., Lee, J., Won, N., Kim, J., Park, I., Yoon, D., & Min, B. (2007) · International Journal of Cancer · doi:10.1002/ijc.22322 · Cited by 165 · see citing works

Molecular profiling of platinum resistant ovarian cancer

Helleman, J., Jansen, M. P. H. M., Span, P. N., van Staveren, I. L., Massuger, L. F. A. G., Gelder, M. E. M., Sweep, F. C. G. J., Ewing, P. C., van der Burg, M. E. L., Stoter, G., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21599 · Cited by 165 · see citing works

A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients

Yang, T., Lu, S., Chao, Y., Sheen, I.-S., Lin, C.-C., Wang, T., Chen, S.-C., Wang, J., Liao, L.-Y., Thomson, J. A., et al. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605856 · Cited by 160 · see citing works

ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance

Huang, H.-Y., Wu, W.-R., Wang, Y.-H., Wang, J., Fang, F.-M., Tsai, J.-W., Li, S.-H., Hung, H.-C., Yu, S.-C., Lan, J., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2641 · Cited by 154 · see citing works

Pancreatic cancer cell lines deficient in argininosuccinate synthetase are sensitive to arginine deprivation by arginine deiminase

Bowles, T. L., Kim, R., Galante, J., Parsons, C. M., Virudachalam, S., Kung, H., & Bold, R. J. (2008) · International Journal of Cancer · doi:10.1002/ijc.23723 · Cited by 153 · see citing works

Prognostic and Therapeutic Impact of Argininosuccinate Synthetase 1 Control in Bladder Cancer as Monitored Longitudinally by PET Imaging

Allen, M. D., Luong, P., Hudson, C. D., Leyton, J., Delage, B., Ghazaly, E. A., Cutts, R. J., Yuan, M., Syed, N., Nigro, C. L., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1702 · Cited by 153 · see citing works

Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma

Ott, P. A., Carvajal, R. D., Pandit-Taskar, N., Jungbluth, A. A., Hoffman, E. W., Wu, B.-W., Bomalaski, J. S., Venhaus, R., Pan, L., Old, L. J., et al. (2013) · Investigational New Drugs · doi:10.1007/s10637-012-9862-2 · Cited by 146 · see citing works

Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosis

Delage, B., Luong, P., Maharaj, L., Ó’Riain, C., Syed, N., Crook, T., Hatzimichael, E. C., Papoudou‐Bai, A., Mitchell, T. J., Whittaker, S. J., et al. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.83 · Cited by 144 · see citing works

Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1α/Sp4

Tsai, W.-B., Aiba, I., Lee, S.-Y., Feun, L. G., Savaraj, N., & Kuo, M. T. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0794 · Cited by 141 · see citing works

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer

Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133 · see citing works

Regulation of mRNA levels for five urea cycle enzymes in rat liver by diet, cyclic AMP, and glucocorticoids

Morris, S. M., Moncman, C. L., Rand, K. D., Dizikes, G. J., Cederbaum, S. D., & O’Brien, W. E. (1987) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(87)90455-3 · Cited by 125 · see citing works

Epigenetic silencing mediated by CpG island methylation: potential as a therapeutic target and as a biomarker

Teodoridis, J. M., Strathdee, G. R., & Brown, R. E. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.06.005 · Cited by 123 · see citing works

Reduced Argininosuccinate Synthetase Is a Predictive Biomarker for the Development of Pulmonary Metastasis in Patients with Osteosarcoma

Kobayashi, E., Masuda, M., Nakayama, R. T., Ichikawa, H., Satow, R., Shitashige, M., Honda, K., Yamaguchi, U., Shoji, A., Tochigi, N., et al. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0774 · Cited by 120 · see citing works

Pegylated arginine deiminase: a novel anticancer enzyme agent

Feun, L. G., & Savaraj, N. (2006) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.15.7.815 · Cited by 118 · see citing works

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Kelly, M. P., Jungbluth, A. A., Wu, B.-W., Bomalaski, J. S., Old, L. J., & Ritter, G. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.524 · Cited by 117 · see citing works

Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminase

Feun, L. G., Marini, A., Walker, G., Elgart, G., Moffat, F., Rodgers, S. E., Wu, C. J., You, M., Wangpaichitr, M., Kuo, M. T., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.106 · Cited by 113 · see citing works

Tumor necrosis factor-α reduces argininosuccinate synthase expression and nitric oxide production in aortic endothelial cells

Goodwin, B. L., Pendleton, L. C., Levy, M. M., Solomonson, L. P., & Eichler, D. C. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01100.2006 · Cited by 110 · see citing works

Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma

Savaraj, N., You, M., Wu, C., Wangpaichitr, M., Kuo, M. T., & Feun, L. G. (2010) · Current Molecular Medicine · doi:10.2174/156652410791316995 · Cited by 108 · see citing works

Glutamine Stimulates Argininosuccinate Synthetase Gene Expression through Cytosolic O-Glycosylation of Sp1 in Caco-2 Cells

Brasse‐Lagnel, C., Fairand, A., Lavoinne, A., & Husson, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306752200 · Cited by 77 · see citing works

Aberrant regulation of argininosuccinate synthetase by TNF‐α in human epithelial ovarian cancer

Szlosarek, P. W., Grimshaw, M. J., Wilbanks, G. D., Hagemann, T., Wilson, J. L., Burke, F., Stamp, G., & Balkwill, F. R. (2007) · International Journal of Cancer · doi:10.1002/ijc.22666 · Cited by 61 · see citing works

Long‐chain fatty acids suppress the induction of urea cycle enzyme genes by glucocorticoid action

Tomomura, M., Tomomura, A., Musa, D. M. A. A., & Saheki, T. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01344-0 · Cited by 46 · see citing works

World Conference on Lung Cancer

Felip, E., & Rosell, R. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.8.1295 · Cited by 45 · see citing works

Coinduction of inducible nitric oxide synthase and arginine recycling enzymes in cytokine-stimulated PC12 cells and high output production of nitric oxide

Zhang, W. Y., Gotoh, T., Oyadomari, S., & Mori, M. (2000) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00154-6 · Cited by 44 · see citing works

Glutamine and interleukin‐1β interact at the level of Sp1 and nuclear factor‐κB to regulate argininosuccinate synthetase gene expression

Brasse‐Lagnel, C., Lavoinne, A., Loeber, D., Fairand, A., Bôle‐Feysot, C., Deniel, N., & Husson, A. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06047.x · Cited by 35 · see citing works

The relationship of arginine deprivation, argininosuccinate synthetase and cell death in melanoma.

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Europe PMC (PubMed Central) · Cited by 32 · see citing works

Anti-tumor Efficacy of a Recombinant Human Arginase in Human Hepatocellular Carcinoma

Chow, A. K.-M., Ng, L., Li, H. S., Cheng, C. W., Lam, C. S. C., Yau, T. C. C., Cheng, P., Fan, S. T., Poon, R. T. P., & Pang, R. W. C. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803988002 · Cited by 32 · see citing works

Novel Pathways and Molecular Targets for the Treatment of Sarcoma

Frith, A. E., Hirbe, A. C., & Tine, B. A. V. (2013) · Current Oncology Reports · doi:10.1007/s11912-013-0319-3 · Cited by 30 · see citing works

The Relationship of Arginine Deprivation, Argininosuccinate Synthetase and Cell Death in Melanoma

Savaraj, N., Wu, C., Kuo, M. T., You, M., Wangpaichitr, M., Robles, C., Spector, S. A., & Feun, L. G. (2007) · Drug Target Insights · doi:10.1177/117739280700200016 · Cited by 30 · see citing works

The emerging hallmarks of cancer metabolism

Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · see citing works

Metabolism of Amino Acids in Cancer

Wei, Z. C., Liu, X., Cheng, C., Yu, W., & Yi, P. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.603837 · Cited by 439 · see citing works

Arginine Signaling and Cancer Metabolism

Chen, C., Hsu, S.-C., Ann, D. K., Yen, Y., & Kung, H.-J. (2021) · Cancers · doi:10.3390/cancers13143541 · Cited by 276 · see citing works

Arginine dependence of tumor cells: targeting a chink in cancer’s armor

Patil, M. D., Bhaumik, J., Babykutty, S., Banerjee, U. C., & Fukumura, D. (2016) · Oncogene · doi:10.1038/onc.2016.37 · Cited by 268 · see citing works

Metabolic rearrangements in primary liver cancers: cause and consequences

Satriano, L., Lewińska, M., Rodrigues, P. M., Bañales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 241 · see citing works

Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma

Abou‐Alfa, G. K., Qin, S., Ryoo, B., Lu, S., Yen, C.-J., Feng, Y., Lim, H. Y., Izzo, F., Colombo, M., Sarker, D., et al. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy101 · Cited by 236 · see citing works

Metabolic reprogramming in renal cancer: Events of a metabolic disease

Chakraborty, S., Balan, M., Sabarwal, A., Choueiri, T. K., & Pal, S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188559 · Cited by 208 · see citing works

Metabolic pathways of L-arginine and therapeutic consequences in tumors

Szefel, J., Danielak, A., & Kruszewski, W. J. (2018) · Advances in Medical Sciences · doi:10.1016/j.advms.2018.08.018 · Cited by 155 · see citing works

Arginine Metabolism in Bacterial Pathogenesis and Cancer Therapy

Xiong, L., Teng, J. L. L., Botelho, M. G., Lo, R. C., Lau, S. K. P., & Woo, P. C. Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17030363 · Cited by 152 · see citing works

The Janus-like role of proline metabolism in cancer

Burke, L. E. C.-A., Guterman, I., Palacios-Gallego, R., Britton, R. G., Burschowsky, D., Tufarelli, C., & Rufini, A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00341-8 · Cited by 128 · see citing works

Metabolic reprogramming in hepatocellular carcinoma: mechanisms and therapeutic implications

Park, S., & Hall, M. N. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01415-2 · Cited by 108 · see citing works

Sensitivity of Colorectal Cancer to Arginine Deprivation Therapy is Shaped by Differential Expression of Urea Cycle Enzymes

Alexandrou, C., Al-Aqbi, S. S., Higgins, J. A., Boyle, W., Karmokar, A., Andreadi, C., Luo, J., Moore, D. A., Viskaduraki, M., Blades, M., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30591-7 · Cited by 86 · see citing works

Arginine-Depleting Enzymes – An Increasingly Recognized Treatment Strategy for Therapy-Refractory Malignancies

Riess, C., Shokraie, F., Classen, C. F., Kreikemeyer, B., Fiedler, T., Junghanß, C., & Maletzki, C. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495382 · Cited by 86 · see citing works

Metabolic alterations and vulnerabilities in hepatocellular carcinoma

Tenen, D. G., Chai, L., & Tan, J. L. (2020) · Gastroenterology report · doi:10.1093/gastro/goaa066 · Cited by 74 · see citing works

Argininosuccinate synthetase 1 contributes to gastric cancer invasion and progression by modulating autophagy

Tsai, C., Chi, H., Chi, L., Yang, H., Tsai, M.-M., Lee, K., Huang, H., Chou, L., Cheng, A., Yang, C., et al. (2018) · The FASEB Journal · doi:10.1096/fj.201700094r · Cited by 66 · see citing works

Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation

Long, Y., Tsai, W.-B., Chang, J. T., Estecio, M. R., Wangpaichitr, M., Savaraj, N., Feun, L. G., Chen, H. H. W., & Kuo, M. T. (2016) · Oncotarget · doi:10.18632/oncotarget.12308 · Cited by 62 · see citing works

Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism

Yeon, A., You, S., Kim, M., Gupta, A., Park, M. H., Weisenberger, D. J., Liang, G., & Kim, J. (2018) · Theranostics · doi:10.7150/thno.25130 · Cited by 61 · see citing works

Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression

Sciacovelli, M., Dugourd, A. J. F., Valcárcel-Jiménez, L., Yang, M. H., Nikitopoulou, E., Costa, A. S. H., Tronci, L., Caraffini, V., Rodrigues, P., Schmidt, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35036-4 · Cited by 60 · see citing works

Argininosuccinate synthase 1 is an intrinsic Akt repressor transactivated by p53

Miyamoto, T., Lo, P. H. Y., Saichi, N., Ueda, K., Hirata, M., Tanikawa, C., & Matsuda, K. (2017) · Science Advances · doi:10.1126/sciadv.1603204 · Cited by 59 · see citing works

Inhibition of the Polyamine Synthesis Pathway Is Synthetically Lethal with Loss of Argininosuccinate Synthase 1

Locke, M., Ghazaly, E. A., Freitas, M. O., Mitsinga, M., Lattanzio, L., Nigro, C. L., Nagano, A., Wang, J., Chelala, C., Szlosarek, P. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.097 · Cited by 57 · see citing works

Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells

Yeh, T.-H., Chen, Y.-R., Chen, S., Shen, W., Ann, D. K., Zaro, J. L., & Shen, L. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00706 · Cited by 53 · see citing works

Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis

Trott, J. F., Hwang, V. J., Ishimaru, T., Chmiel, K. J., Zhou, J. X., Shim, K., Stewart, B. J., Mahjoub, M. R., Jen, K., Barupal, D. K., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00025.2018 · Cited by 52 · see citing works

Histone Acetyltransferase 1 Promotes Cell Proliferation and Induces Cisplatin Resistance in Hepatocellular Carcinoma

Jin, X., Tian, S., & Li, P. (2017) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504016x14809827856524 · Cited by 46 · see citing works

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies

Harding, J. J., Do, R. K., Dika, I. E., Hollywood, E. M., Uhlitskykh, K., Valentino, E., Wan, P., Hamilton, C. R., Feng, X., Johnston, A. L., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3635-3 · Cited by 44 · see citing works

Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma

Tao, X., Zuo, Q., Ruan, H., Wang, H., Jin, H., Cheng, Z., Lv, Y., Qin, W., & Wang, C. (2019) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmz005 · Cited by 44 · see citing works

Arginine deiminase: recent advances in discovery, crystal structure, and protein engineering for improved properties as an anti-tumor drug

Han, R., Xu, G., Dong, J., & Ni, Y. (2016) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-7490-z · Cited by 43 · see citing works

Unlocking the Potential of Arginine Deprivation Therapy: Recent Breakthroughs and Promising Future for Cancer Treatment

Chu, Y., Lai, M., & Yeh, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310668 · Cited by 42 · see citing works

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies

Yao, S., Jankú, F., Subbiah, V., Stewart, J., Patel, S. P., Kaseb, A. O., Westin, S. N., Naing, A., Tsimberidou, A. M., Hong, D. S., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01230-8 · Cited by 41 · see citing works

Metabolic Strategies for Inhibiting Cancer Development

Icard, P., Loi, M., Wu, Z., Ginguay, A., Lincet, H., Robin, E., Coquerel, A., Berzan, D., Fournel, L., & Alifano, M. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa174 · Cited by 36 · see citing works

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma

Thongkum, A., Wu, C., Li, Y.-Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Ruchirawat, M., & Savaraj, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061175 · Cited by 33 · see citing works

Molecular network of metabolic reprogramming and precision diagnosis and treatment of hepatocellular carcinoma

An, L., & Li, Z. (2025) · Biomarker Research · doi:10.1186/s40364-025-00844-5 · Cited by 32 · see citing works

The conjugates of ferrocene-1,1′-diamine and amino acids. A novel synthetic approach and conformational analysis

Kovačević, M., Kodrin, I., Cetina, M., Kmetič, I., Murati, T., Semenčić, M. Č., Roca, S., & Barišić, L. (2015) · Dalton Transactions · doi:10.1039/c5dt01610j · Cited by 28 · see citing works

Phase 1 trial of ADI‐PEG 20 and liposomal doxorubicin in patients with metastatic solid tumors

Yao, S., Jankú, F., Koenig, K. B., Tsimberidou, A. M., Piha-Paul, S. A., Shi, N., Stewart, J., Johnston, A. L., Bomalaski, J. S., Meric‐Bernstam, F., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4446 · Cited by 24 · see citing works

Cytosolic Delivery of Argininosuccinate Synthetase Using a Cell-Permeant Miniature Protein

Knox, S. L., Wissner, R. F., Piszkiewicz, S., & Schepartz, A. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01603 · Cited by 21 · see citing works

Partial least squares regression and fourier transform infrared (FTIR) microspectroscopy for prediction of resistance in hepatocellular carcinoma HepG2 cells

Junhom, C., Weerapreeyakul, N., Tanthanuch, W., & Thumanu, K. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.12.027 · Cited by 20 · see citing works

Pegylated arginine deiminase drives arginine turnover and systemic autophagy to dictate energy metabolism

Zhang, Y., Higgins, C. B., Tine, B. A. V., Bomalaski, J. S., & DeBosch, B. J. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100498 · Cited by 17 · see citing works

SLC7A5 is required for cancer cell growth under arginine-limited conditions

Dunlap, K., Bender, A., Bowles, A., Bott, A. J., Tay, J., Grossmann, A. H., Rutter, J. P., & Ducker, G. S. (2025) · Cell Reports · doi:10.1016/j.celrep.2024.115130 · Cited by 16 · see citing works

Proteomic Analysis Reveals that EPHX1 Contributes to 5‐Fluorouracil Resistance in a Human Hepatocellular Carcinoma Cell Line

Sun, R., Dong, C., Li, R., Chu, H., Liu, J., Hao, D., Zhang, L., Zhao, B., Wang, L., & Zhang, Y. (2020) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201900080 · Cited by 15 · see citing works

Decreased argininosuccinate synthetase expression in Thai patients with cholangiocarcinoma and the effects of ADI‑PEG20 treatment in CCA cell lines

Roeksomtawin, S., Navasumrit, P., Waraprasit, S., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Savaraj, N., & Ruchirawat, M. (2018) · Oncology Letters · doi:10.3892/ol.2018.8807 · Cited by 14 · see citing works

Aluminum chloride causes 5‐fluorouracil resistance in hepatocellular carcinoma HepG2 cells

Li, M., Cui, Z., Zakki, S. A., Feng, Q., Sun, L., Feril, L. B., & Inadera, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28625 · Cited by 14 · see citing works

Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single‐arm, phase 2 study

Harding, J. J., Yang, T., Chen, Y., Feng, Y., Yen, C., Ho, C., Huang, W., Dika, I. E., Akce, M., Tan, B. R., et al. (2021) · Cancer · doi:10.1002/cncr.33870 · Cited by 14 · see citing works

Cholesterol-Conjugate as a New Strategy to Improve the Cytotoxic Effect of 5-Fluorouracil on Liver Cancer: Impact of Liposomal Composition

Alanazi, S. A., Harisa, G. I., Badran, M. M., Haq, N., Radwan, A. A., Kumar, A., Shakeel, F., & Alanazi, F. K. (2020) · Current Drug Delivery · doi:10.2174/1567201817666200211095452 · Cited by 13 · see citing works

A pan-cancer analysis of the role of argininosuccinate synthase 1 in human tumors

Ding, Q., Li, R., Wang, Q., Li, Y., & Zi, F. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1049147 · Cited by 12 · see citing works

A modified arginine-depleting enzyme NEI-01 inhibits growth of pancreatic cancer cells

Chow, J. P. H., Cai, Y., Chow, D. T. L., Chung, S. H. K., Chau, K.-C., Ng, K.-Y., Leung, O. M., Wong, R. M. H., Law, A. W. L., Leung, Y.-O., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231633 · Cited by 12 · see citing works

Cell Penetrating Peptide: Sequence-Based Computational Prediction for Intercellular Delivery of Arginine Deiminase

Zarei, M., Rahbar, M. R., Negahdaripour, M., Morowvat, M. H., Nezafat, N., & Ghasemi, Y. (2019) · Current Proteomics · doi:10.2174/1570164616666190701120351 · Cited by 11 · see citing works

Methylation synthetic lethality: Exploiting selective drug targets for cancer therapy

Ye, B.-J., Li, D.-F., Li, X., Hao, J.-L., Liu, D.-J., Yu, H., & Zhang, C. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217010 · Cited by 9 · see citing works

m 6 A‐Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism

Shi, J., Mui, S., Yan, Y., Liu, S., Wen, K., He, C., Li, H., Liao, H., Meng, T., Wen, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202503851 · Cited by 9 · see citing works

Impaired nitrogenous waste clearance promotes hepatocellular carcinoma

Han, X., Shen, J., Yan, J., Tacke, R., Dai, W., Mao, Q., Queen, H., Liu, S., Islam, A., Liu, T., et al. (2026) · Science Advances · doi:10.1126/sciadv.aec0766 · Cited by 7 · see citing works

Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma

Kim, J. S., Choi, W., Kim, H. I., Chung, S. W., Choi, J., Lee, D., & Kim, K. M. (2025) · Journal of Liver Cancer · doi:10.17998/jlc.2024.12.27 · Cited by 6 · see citing works

Label-free Raman spectroscopy reveals tumor microenvironmental changes induced by intermittent fasting for the prevention of breast cancer in animal model

Zheng, C., Yu, L., Zhao, L., Guo, M., Feng, M., Li, H., Zhou, X., Fan, Y., Liu, L., Ma, Z., et al. (2024) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2024.124387 · Cited by 4 · see citing works

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production

Nagel, R., Kochavi, A., Karlsen, K. F., Adhikary, M., Gal-On, Y., Klaoudatou, M. G., Champagne, J., Valcanover, L., Palashati, H., Nielsen, M. M., et al. (2026) · Cancer Research · doi:10.1158/0008-5472.can-25-4773 · Cited by 4 · see citing works

Analysis of Arginine Metabolism Using LC-MS and Isotopic Labeling

Seim, G. L., Britt, E. C., & Fan, J. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9236-2_13 · Cited by 4 · see citing works

A novel Romani microdeletion variant in the promoter sequence of ASS1 causes citrullinemia type I

Imagawa, E., Díaz, G. A., & Oishi, K. (2020) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2020.100619 · Cited by 4 · see citing works

Bis[N,N′-bis(anilino)glioximato]platinum(II) complex: synthesis, characterization and biological activity

Gülümsek, Ö. E., Baykal, E. E., Küçükpolat, C., Önal, E., Balçık-Erçin, P., Yağcı, T., Ahsen, V., & Gürek, A. G. (2022) · Journal of Coordination Chemistry · doi:10.1080/00958972.2022.2028779 · Cited by 4 · see citing works

In silico and in vitro analysis of arginine deiminase from Pseudomonas furukawaii as a potential anticancer enzyme

Dhankhar, R., Kawatra, A., Gupta, V., Mohanty, A., & Gulati, P. (2022) · 3 Biotech · doi:10.1007/s13205-022-03292-2 · Cited by 4 · see citing works

Tumor starvation by L-arginine deprivation

Fried, R., Carlton, R. M., & Fried, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824013-7.00005-5 · Cited by 2 · see citing works

Arginine deiminase-polymeric hybrid nanoconjugates: A potential biodrug for targeted treatment of arginine auxotrophic cancers

Kawatra, A., & Gulati, P. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.143679 · Cited by 1 · see citing works

The impact of p53 on the urea cycle and nitrogen metabolism enzymes: Mechanisms and implications for cancer development

Iyer, S., & Schlichtholz, B. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168024 · Cited by 1 · see citing works

Evodiamine Inhibits Colorectal Cancer by Downregulating ASS1 via Wnt/β-Catenin/c-MYC Pathway to Block Arginine Synthesis

Wang, H., Deng, H., He, J., Ma, J., Li, Y., Lv, H., Ran, J., Chen, D., & Li, J. (2025) · Pharmaceuticals · doi:10.3390/ph18111736 · Cited by 1 · see citing works

Targeting arginine metabolism overcomes chemotherapy resistance in aggressive-variant prostate cancers

Subramani, E., Pilie, P. G., Slack-Tidwell, R., Viscuse, P. V., Kuang, X., Kandasamy, T., Awad, D., Han, J. J., Huang, L., Peterson, C. B., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116184 · Cited by 1 · see citing works

BRAF Inhibitor (Vemurafenib) Resistance Confers Sensitivity to Arginine Deprivation in Melanoma

Li, Y. (2016)

Characterizing the effect of arginine deprivation on breast cancer cell migration and proliferation. (2021)

Hajj, G. E. (2021) · doi:10.26756/th.2022.174

The output of bacterial L-arginase using 16S rRNA from different soil environments in Egypt as an anticancer agent

Kassab, M. M. S. (2026) · International Journal of Medical Arts · doi:10.21608/ijma.2026.362854.2136

Research advances on amino acid starvation interventions for hepatocellular carcinoma

Li, Y., Li, L., Hou, Y., Peng, X., & Li, H. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189400

Impact of metabolic reprogramming on the immune response in hepatocellular carcinoma

Wang, Y., Lu, Y.-J., Zhou, J., & Yang, X.-R. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2025.105

Research Progress on Argininosuccinate Synthetase 1 in Tumor Metabolism and Precision Therapy

刘, 佳. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.16103561

RESEARCH ARTICLE Open Access Down-regulation of argininosuccinate synthetase

McAlpine, J. A. (2016)

Synergistic effects of L-arginine and argininosuccinate synthetase 1 in inducing apoptosis in hepatocellular carcinoma

Kim, J. S., Choi, W., Kim, H. I., Chung, S. W., Choi, J., Lee, D., & Kim, K. M. (2025) · Journal of Liver Cancer · doi:10.17998/jlc.2024.12.27 · Cited by 6 · see citing works

Argininosuccinate synthetase 1 (ASS1) expression and response to arginine deprivation with ADI-PEG20 in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma (HNSCC).

Howard, J. D., Pérez, J., Slebos, R. J. C., & Chung, C. H. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.e17041 · Cited by 1 · see citing works

Pegylated Recombinant Human Arginase (rhArg-peg5,000mw) Inhibits the In vitro and In vivo Proliferation of Human Hepatocellular Carcinoma through Arginine Depletion

Cheng, P., Lam, T. L., Lam, W.-M., Tsui, S. M., Cheng, A. W. M., Lo, W. H., & Leung, Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1945 · Cited by 279 · see citing works

Epigenetic silencing of argininosuccinate synthetase confers resistance to platinum-induced cell death but collateral sensitivity to arginine auxotrophy in ovarian cancer

Nicholson, L. J., Smith, P. R., Hiller, L., Szlosarek, P. W., Kimberley, C., Sehouli, J., Koensgen, D., Mustea, A., Schmid, P., & Crook, T. (2009) · International Journal of Cancer · doi:10.1002/ijc.24546 · Cited by 133 · see citing works